Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Aprinoia Therapeutics completes series B financing round

Jan. 16, 2018

FDA approves Lynparza for BRCA-mutated metastatic breast cancer

Jan. 15, 2018

Horizon Discovery in agreement with Roche Diagnostics to support development of IHC assays

Dec. 18, 2017

Telix and Memorial Sloan Kettering collaborate on TLX-250 to image clear cell RCC

Dec. 15, 2017

FDA approves FoundationOne CDx diagnostic test

Dec. 1, 2017

Novel tracer targets angiomotin for brain tumor imaging

Nov. 8, 2017

Clinical results encourage use of [68Ga]DATATOC for imaging neuroendocrine tumors

Nov. 8, 2017

Clinical evaluation of 177Lu-PP-F11N underway in medullary thyroid cancer

Nov. 6, 2017

First-in-human study reported for next-generation PET tau tracer 18F-PI-2620

Nov. 3, 2017

[Ga68]PSMA bimodal probe for radio- and fluorescence-guided surgery of prostate cancer

Oct. 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...